sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Asia Pacific Biodefense Market Scope And Analysis

  • Report Code : TIPRE00010409
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 100
Buy Now

Asia Pacific Biodefense Market Scope and Key Players Analysis by 2027

Buy Now

Asia Pacific Biodefense Market Report Asia Pacific Biodefense Market Size and Share Asia Pacific Biodefense Market Scope and Analysis

Asia Pacific Biodefense Market Report Scope

Report Attribute Details
Market size in 2019 US$ 1,520.67 Million
Market Size by 2027 US$ 723.70 Million
Global CAGR (2019 - 2027) 9.8%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Product
  • Anthrax
  • Small pox
  • Botulism
  • Radiation/Nuclear
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Bavarian Nordic
  • Alnylam Pharmaceuticals Inc
  • SIGA Technologies
  • Emergent BioSolutions Inc
  • Cleveland Bio Labs
  • Dynavax Technologies
  • Elusys Therapeutics Inc
  • Soligenix
  • Altimmune